Compare BTMD & FRMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTMD | FRMM |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.4M | 54.9M |
| IPO Year | 2021 | 2017 |
| Metric | BTMD | FRMM |
|---|---|---|
| Price | $2.22 | $4.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $2.83 | ★ $5.00 |
| AVG Volume (30 Days) | 303.3K | ★ 2.7M |
| Earning Date | 05-06-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 722.22 | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $192,219,000.00 | N/A |
| Revenue This Year | $2.03 | $183.55 |
| Revenue Next Year | $6.58 | $166.48 |
| P/E Ratio | $3.03 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.27 | $1.76 |
| 52 Week High | $4.75 | $5.55 |
| Indicator | BTMD | FRMM |
|---|---|---|
| Relative Strength Index (RSI) | 69.22 | 70.15 |
| Support Level | $2.02 | $2.64 |
| Resistance Level | $2.79 | $5.55 |
| Average True Range (ATR) | 0.15 | 0.56 |
| MACD | 0.08 | 0.29 |
| Stochastic Oscillator | 85.39 | 75.20 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.